0
1. 9. 2024.
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions.
Neoadjuvant and Adjuvant Immune-based Approach for Renal Cell Carcinoma: Pros, Cons, and Future Directions.
Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo
Saznaj više